Department of Molecular Pharmacology and Physiology, University of South Florida Morsani College of Medicine, Tampa, FL, United States.
Department of Anesthesiology and Critical Care, University of California, San Diego, Veterans Affairs San Diego Healthcare System, San Diego, CA, United States.
Front Immunol. 2020 Sep 11;11:586685. doi: 10.3389/fimmu.2020.586685. eCollection 2020.
Gut ischemia/reperfusion (I/R) injury is a common clinical problem associated with significant mortality and morbidities that result from systemic inflammation and remote organ dysfunction, typically acute lung injury. The mechanisms underlying the dissemination of gut-derived harmful mediators into the circulation are poorly understood. The objective of our study was to determine the role of mesenteric lymphatic circulation in the systemic and pulmonary inflammatory response to gut I/R. Using a murine intestinal I/R model, we evaluated whether and how blocking mesenteric lymph flow affects the inflammatory response in local tissues (gut) and remote organs (lungs). We further explored the mechanisms of post-I/R lymph-induced systemic inflammation by examining neutrophil activity and interaction with endothelial cells . Mice subjected to intestinal I/R displayed a significant inflammatory response in local tissues, evidenced by neutrophil infiltration into mucosal areas, as well as lung inflammation, evidenced by increased myeloperoxidase levels, neutrophil infiltration, and elevated microvascular permeability in the lungs. Mesenteric lymph duct ligation (MLDL) had no effect on gut injury , but effectively attenuated lung injury following gut I/R. Cell experiments showed that lymph fluid from post-I/R animals, but not pre-I/R, increased neutrophil surface CD11b expression and their ability to migrate across vascular endothelial monolayers. Moreover, post-I/R lymph upregulated neutrophil expression of pro-inflammatory cytokines and chemokines, which was mediated by a mechanism involving nuclear factor (NF)-κB signaling. Consistently, gut I/R activated NF-κB in lung neutrophils, which was alleviated by MLDL. In conclusion, all these data indicate that mesenteric lymph circulation contributes to neutrophil activation and lung inflammation following gut I/R injury partly through activating NF-κB.
肠缺血/再灌注(I/R)损伤是一种常见的临床问题,与全身性炎症和远程器官功能障碍(通常是急性肺损伤)相关,导致显著的死亡率和发病率。肠源性有害介质向循环系统扩散的机制尚不清楚。我们的研究目的是确定肠系膜淋巴循环在肠道 I/R 后全身和肺部炎症反应中的作用。使用小鼠肠道 I/R 模型,我们评估了阻断肠系膜淋巴流动是否以及如何影响局部组织(肠道)和远程器官(肺部)的炎症反应。我们进一步通过检查中性粒细胞活性和与内皮细胞的相互作用,探讨了 I/R 后淋巴引起的全身炎症的机制。肠道 I/R 小鼠显示出局部组织的明显炎症反应,表现为黏膜区域中性粒细胞浸润,以及肺部炎症,表现为髓过氧化物酶水平升高、中性粒细胞浸润和肺部微血管通透性升高。肠系膜淋巴导管结扎(MLDL)对肠道损伤没有影响,但有效减轻了肠道 I/R 后的肺损伤。细胞实验表明,来自 I/R 后动物的淋巴液,但不是 I/R 前的淋巴液,增加了中性粒细胞表面 CD11b 的表达及其穿过血管内皮单层的迁移能力。此外,I/R 后淋巴液上调了中性粒细胞表达促炎细胞因子和趋化因子,这一机制涉及核因子(NF)-κB 信号通路。一致地,肠道 I/R 激活了肺中性粒细胞中的 NF-κB,MLDL 减轻了这种激活。总之,这些数据表明,肠系膜淋巴循环通过激活 NF-κB 部分促进了肠道 I/R 损伤后中性粒细胞的激活和肺部炎症。